Tag: Kathrin Jansen

BioNTech, Pfizer join forces to develop mRNA-based flu vaccines

pharmanewsdaily- August 19, 2018

BioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part of a $425 million multi-year ... Read More